Locally Advanced Rectal Cancer: Clinical Trials

4 trials for Locally Advanced Rectal Cancer, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 not yet recruiting, 1 recruiting, 1 unknown. 4 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 34Completed 1, Not yet recruiting 1, Recruiting 1, Unknown 1

Follow Locally Advanced Rectal Cancer: new trials by email Literature Review of Locally Advanced Rectal Cancer trials Research Report on Locally Advanced Rectal Cancer

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Irinotecan Liposomes in Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer
NALIRI, LCRT, FOLFOX - Locally Advanced Rectal Cancer
Phase 3Not yet recruitingZhejiang Cancer Hospital3602025-07-202025-07-25
TNT of SCRT+CAPOX vs SCRT+CAPOXIRI for Locally Advanced Rectal Cancer
SCRT, CAPOX, CAPOXIRI - Locally Advanced Rectal Cancer
Phase 3RecruitingNational Cancer Center Hospital East6082022-11-212025-04-03
Dendrobium Huoshanense Suppository in Rectal Cancer
Dendrobium Huoshanense Suppository - Locally Advanced Rectal Cancer
Phase 3UnknownZhejiang Cancer Hospital1682021-09-072021-10-15
Trial of Capecitabine With or Without Irinotecan Driven by UGT1A1
Radiation, Capecitabine, Irinotecan - Locally Advanced Rectal Cancer
Phase 3CompletedFudan University3562015-10-012025-08-28

Narrower conditions

Colorectal Neoplasms (1)  ·  Digestive System Neoplasms (1)  ·  Gastrointestinal Neoplasms (1)  ·  Intestinal Neoplasms (1)  ·  Rectal Neoplasms (1)

Broader conditions

Colonic Diseases (1)  ·  Digestive System Diseases (1)  ·  Gastrointestinal Diseases (1)  ·  Intestinal Diseases (1)  ·  Neoplasms (1)  ·  Neoplasms by Site (1)  ·  Rectal Diseases (1)

Interventions

Capecitabine (1)  ·  Folfox protocol (1)  ·  Irinotecan (1)  ·  Oxaliplatin (1)  ·  Radiation (1)

Sponsors

Zhejiang Cancer Hospital (2)  ·  Fudan University (1)  ·  National Cancer Center Hospital East (1)

Countries

China (3)  ·  Japan (1)

Top investigators

Zhen Zhang, MD (1)

Results publications

PMID 31217818, PMID 31761724, PMID 33119477, PMID 34178635, PMID 40899645